← All trials
NCT06538883
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2024
- Primary completion
- Jun 30, 2026
- Completion date
- Jul 30, 2026
- First posted
- Aug 6, 2024
- Last posted
- Aug 6, 2024
- Enrollment
- 366
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Southeast UniversityLead sponsor
- Nanchang UniversityCollaborator
- Shanghai Xuhui District Central HospitalCollaborator
- Henan Provincal People's HospitalCollaborator
- Wuhan UniversityCollaborator
- Sichuan UniversityCollaborator
- First People's Hospital of HangzhouCollaborator
- Xiamen UniversityCollaborator
- The First People's Hospital of LianyungangCollaborator
- Kunming Medical UniversityCollaborator
- Hebei UniversityCollaborator
- Huai'an First People's HospitalCollaborator
- Southeast UniversitySponsor investigator
- Suzhou Medical CollegeCollaborator
- The First People’s Hospital of ZunyiCollaborator
- Sun Yat-Sen UniversityCollaborator
- Jiangxi Provincial People's HospitalCollaborator
- Soochow UniversityCollaborator
- People's Liberation Army of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.